MedPath

An in-depth investigation and analysis were conducted on the real-world effectiveness of the Adaptix™ Interbody Cage System at a specialized spine center providing tertiary care.

Not Applicable
Conditions
Health Condition 1: M431- Spondylolisthesis
Registration Number
CTRI/2024/01/061495
Lead Sponsor
Stavya Spine Hospital and Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the cases who undergoing inter-body fusion with Adaptix™ inter-body system.

cases giving consent for surgery.

age group 18 and above

Exclusion Criteria

patients who are not willing to be a part of study.

Age below 18.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the safety and performance of Adaptix™ through retrospective review of cases Done at our institute. <br/ ><br>To identify residual risk for Adaptix™. <br/ ><br>Identify off possible label use. <br/ ><br>Identify previously unknown side effects and complications. <br/ ><br>Timepoint: Visits at 3 months,6 months and 12 months
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath